Stock Taper
KTTA
PASITHEA THERAPEUTICS CORP.
NASDAQ
$0.58
▼ DOWN 0.07% (-0.00)

KEY STATISTICS

Market Cap$19.38 M
52w High$2.06
52w Low$0.28
Dividend Yield
Frequency
P/E-0.36
Volume222.70K
Shares Out.33.41M

COMPANY

LEADERSHIP

Tiago Reis Marques
CHIEF EXECUTIVE
Tiago Reis Marques

COMPENSATION 2026

Salary$533,610
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$23,500
Total$1,327,518

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 15, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
5

PRICE TARGET

Target High$3.00
Target Low$3.00
Target Median$3.00
Target Consensus$3.00

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$200.00K
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2024-01-02Reverse1:20

PRICE

$0.58 ▼ DOWN 0.07% (−$0.00)
OVERLAYS
$0.57$0.58$0.58$0.599:30 AM10:35 AM11:39 AM12:44 PM1:49 PM2:53 PM3:58 PM0.58

About Pasithea Therapeutics Corp.

https://www.pasithea.com ↗

Pasithea Therapeutics Corp. is a Miami Beach-based biotech founded in 2020, focused on developing treatments for psychiatric and neurological disorders, including ketamine infusion clinics and related support services.

INDUSTRY

Biotechnology

A PRODUCT PASITHEA THERAPEUTICS CORP. IS KNOWN FOR

PAS-004
PAS-004

PAS-004 is a next-generation macrocyclic MEK inhibitor in Phase 1/1b trials, developed to treat RASopathies like NF1 and MAPK pathway-driven tumors.

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

10 PERCENT OWNER
Coastlands Capital LP
Purchase · 100.0K shares
2026-06-17
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Marques Tiago
Purchase · 1.8M shares
2026-05-01
DIRECTOR
STEINMAN LAWRENCE
Purchase · 152.8K shares
2026-05-01
DIRECTOR
Dumesnil Simon
Purchase · 152.8K shares
2026-05-01

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
CYCN$4.20COMPARE
QNRX$7.22COMPARE
PLRZ$12.30COMPARE
KALA$0.51COMPARE
TCRT$1.61COMPARE
VIVS$0.28COMPARE